Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Eptifibatide for Sale > Eptifibatide, Eptifibatide Acetate Salt, Integrilin, Eptifibatide API, Eptifibatide Peptide, Peptide
Eptifibatide, Eptifibatide Acetate Salt, Integrilin, Eptifibatide API, Eptifibatide Peptide, Peptide buy - large image1
Eptifibatide, Eptifibatide Acetate Salt, Integrilin, Eptifibatide API, Eptifibatide Peptide, Peptide buy - image1
Eptifibatide, Eptifibatide Acetate Salt, Integrilin, Eptifibatide API, Eptifibatide Peptide, Peptide buy - image2
Eptifibatide, Eptifibatide Acetate Salt, Integrilin, Eptifibatide API, Eptifibatide Peptide, Peptide buy - image3

Eptifibatide, Eptifibatide Acetate Salt, Integrilin, Eptifibatide API, Eptifibatide Peptide, Peptide

GMP FDA COA 2 Inquiries

Unit Price: Get Latest Price
CAS No.:

188627-80-7

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Chengdu

Brand:

Chengdu Shengnuo, Shengnuo Biopharm

Packaging:

g

Price valid (until):

2025-11-15

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Eptifibatide, Eptifibatide Acetate Salt, Integrilin, Eptifibatide API, Eptifibatide Peptide, Peptide

     

    CAS No.:  188627-80-7

    Purity: ≥99% (HPLC)
    Molecular Formula: C35H49N1O9S2

    Theoretical Molecular Weight: 831.96
    Appearance: White to off-white lyophilized powder
    Storage Conditions: -20°C±5°C (dry, protected from light)

     

    Indications

    1. For acute coronary syndrome (unstable angina/non-ST-elevation myocardial infarction), including patients receiving medical therapy and those undergoing PCI, to reduce the incidence of death or new myocardial infarction.
    2. For patients undergoing PCI, including coronary stent placement, to reduce the incidence of death, new myocardial infarction, or urgent intervention.

     

    Certificates

    Basic Info
    Product Name:

    Eptifibatide

    Other Name:

    MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;Intrifiban;N6-(AMinoiMinoMethyl)-N2-(3-Mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-L-cysteinaMide Cyclic (16)-Disulfide;3-Mercaptopropionyl-HoMoarg-Gly-Asp-Trp-Pro-Cys-NH2

    CAS No.:

    188627-80-7

    Molecular Formula:

    C35H49N11O9S2

    InChIKeys:

    CZKPOZZJODAYPZ-UHFFFAOYSA-N

    Molecular Weight:

    831.96

    Exact Mass:

    831.315613

    EC Number:

    1312995-182-4

    DSSTox ID:

    DTXSID7046673

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    377 Ų

    XLogP3:

    log Kow = -4.33 (est)

    Density:

    1.6±0.1 g/cm3

    Refractive Index:

    1.735

    Water Solubility:

    In water, 1108 mg/L at 25 °C (est)

    Storage Conditions:

    Eptifibatide should be refrigerated at between 2-8 °C and protected from light until administration.|Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature -20 °C. Store with desiccant. /Eptifibatide acetate/

    Vapor Pressure:

    1.78X10-40 mm Hg at 25 °C (est)

    Henrys Law Constant:

    Henry's Law constant = 9.88X10-34 atm-cu m/mol at 25 °C (est)

    Experimental Properties:

    Hydroxyl radical reaction rate constant = 6.79X10-10 cu cm/molec-sec at 25 °C (est)

    Hazard Identification

    Classification of the substance or mixture

    Specific target organ toxicity – single exposure, Category 1

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H370 Causes damage to organs

    Precautionary statement(s)
    Prevention

    P260 Do not breathe dust/fume/gas/mist/vapours/spray.

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P308+P316 IF exposed or concerned: Get emergency medical help immediately.

    P321 Specific treatment (see ... on this label).

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1

    Location:

    Chengdu Shengnuo Biopharm Co., Ltd.

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    365

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    Above 1000

    Year of Establishment:

    2004

  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Uzbekistan

    Eptifibatide

    60 G Dec 10, 2023
    India

    Eptifibatide

    10 G May 13, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.